<DOC>
	<DOCNO>NCT01954628</DOCNO>
	<brief_summary>The primary objective study evaluate effect 12 week treatment daily administration AQX-1125 compare placebo subject follow exacerbation Chronic Obstructive Pulmonary Disease ( COPD ) target SHIP1 ( Src Homology 2-containing Inositol-5'-Phosphatase 1 ) pathway .</brief_summary>
	<brief_title>Efficacy Safety AQX-1125 Unstable COPD</brief_title>
	<detailed_description />
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>1 . Male female age â‰¥40 year screen 2 . History COPD least 18 month prior screen , characterise excessive sputum production 3 . Chronic productive cough least 3 month 2 year prior screen ( cause productive cough exclude ) and/or exacerbation COPD predominantly bronchitic symptom enrolment 4 . At least 2 documented exacerbation last 18 month prior screen . 5 . Presentation diagnose acute exacerbation COPD , recently ( within 3 day ) discharge hospital due acute exacerbation COPD 6 . Ability perform pulmonary function test document fixed airway obstruction determine FEV1 /FVC [ force vital capacity ] ratio ( postbronchodilator ) &lt; 0.70 predict FEV1 value 30 % 80 % normal within 6 month prior Visit 1 . 7 . Former smoker current smoker , smoke history least 10 pack year 1 . Diagnosis relevant lung disease ( e.g . asthma , cystic fibrosis [ CF ] significant nonCF bronchiectasis ) 2 . Known alpha1antitrypsin deficiency 3 . Treatment roflumilast theophylline within 1 month prior screen 4 . Lobar pneumonia , current positive chest Xray ( CXR ) within 3 month prior screen include presence new radiological infiltrate CXR within previous two week 5 . Hospitalisation 7 day current acute exacerbation , requirement intubation hospitalisation 6 . For outpatient , prior medical history indicate previous exacerbation require &gt; 3 week stabilise</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Exacerbation COPD</keyword>
	<keyword>Unstable COPD</keyword>
</DOC>